Drug Pipeline

SHR-3167 Injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-05 NCT07472725
A Study Comparing Safety and Efficacy of SHR-3167 Fixed-Dose Titration and…		 overall status: "Not Yet Recruiting" → "Active Not Recruiting"
2026-06-05 NCT07472725
A Study Comparing Safety and Efficacy of SHR-3167 Fixed-Dose Titration and…		 Enrollment increased: 90 -> 102 participants
Active Studies by Phase
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07472725 A Study Comparing Safety and Efficacy of SHR-3167 Fixed-Dose Titration and… Diabetes Mellitus, Type 2 Active, Not Recruiting
Phase 1
NCT07032688 A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of… Type 2 Diabetes Recruiting
NCT07489482 A Clinical Study Comparing the Relative Bioavailability and Safety of SHR-3167 Injection Diabetes Mellitus Recruiting
Sponsors Running SHR-3167 Injection Trials
Jiangsu HengRui Medicine Co., Ltd. (3)
Disease Areas
Diabetes (3) Type 2 Diabetes (1)
Get alerts when SHR-3167 Injection trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free